Kristen Kelley Penberthy

Kristen Kelley Penberthy

Auto-generated profile, based on publicly available information

Kristen Kelley Penberthy

Center for Cell Clearance, University of Virginia, Charlottesville, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2015 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
KPKristen K. Penberthy
Kristen K. Penberthy
KRKodi S. Ravichandran
Kodi S. Ravichandran

31 October 2013 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
AMAlka Mehra
Alka Mehra
AZAleena Zahra
Aleena Zahra
VTVictor Thompson
Victor Thompson
NSNatalie Sirisaengtaksin
Natalie Sirisaengtaksin
AWAshley Wells
Ashley Wells
JPJennifer A. Philips
Jennifer A. Philips
Mycobacterium tuberculosis (Mtb) disrupts anti-microbial pathways of macrophages, cells that normally kill bacteria. Over 40 years ago, D'Arcy Hart showed that Mtb avoids delivery to lysosomes, but the molecular mechanisms that allow Mtb to elude lysosomal degradation are poorly understood. Specialized secretion systems are often used by bacterial pathogens to translocate effectors that target the host, and Mtb encodes type VII secretion systems (TSSSs) that enable mycobacteria to secrete proteins across their complex cell envelope; however, their cellular targets are unknown. Here, we describe a systematic strategy to identify bacterial virulence factors by looking for interactions between the Mtb secretome and host proteins using a high throughput, high stringency, yeast two-hybrid (Y2H) platform. Using this approach we identified an interaction between EsxH, which is secreted by the Esx-3 TSSS, and human hepatocyte growth factor-regulated tyrosine kinase substrate (Hgs/Hrs), a component of the endosomal sorting complex required for transport (ESCRT). ESCRT has a well-described role in directing proteins destined for lysosomal degradation into intraluminal vesicles (ILVs) of multivesicular bodies (MVBs), ensuring degradation of the sorted cargo upon MVB-lysosome fusion. Here, we show that ESCRT is required to deliver Mtb to the lysosome and to restrict intracellular bacterial growth. Further, EsxH, in complex with EsxG, disrupts ESCRT function and impairs phagosome maturation. Thus, we demonstrate a role for a TSSS and the host ESCRT machinery in one of the central features of tuberculosis pathogenesis. Mycobacterium tuberculosis (Mtb) causes the disease tuberculosis, one of the world's most deadly infections. The host immune system can't eradicate Mtb because it grows within macrophages, cells that normally kill bacteria. One of the intracellular survival strategies of Mtb is to avoid delivery to lysosomes, a phenomenon described over 40 years ago, but for which the mechanism and molecular details remain incomplete. Mtb possess specialized secretion systems (Type VII secretion systems; TSSS) that transfer particular proteins out of the bacteria, but how these proteins promote infection is not well understood. In this study, we used a high stringency yeast two-hybrid system to identify interactions between secreted effectors from Mtb and human host factors. We identified ninety-nine such interactions and focused our attention on the interaction between EsxH, secreted by Esx-3, a TSSS of Mtb, and Hrs, a component of the host ESCRT machinery. We provide evidence that Mtb EsxH directly targets host Hrs to disrupt delivery of bacteria to lysosomes. Thus, this study demonstrates the role of a TSSS effector and the ESCRT machinery in what is one of the central features of tuberculosis pathogenesis, thereby providing molecular insight into why humans can't clear Mtb infection.

1 April 2016 in Immunity
Verified
Journal Article
Closed access
CLChang Sup Lee
Chang Sup Lee
KPKristen K. Penberthy
Kristen K. Penberthy
KWKaren M. Wheeler
Karen M. Wheeler
IJIgnacio J. Juncadella
Ignacio J. Juncadella
PVPeter Vandenabeele
Peter Vandenabeele
KRKodi S. Ravichandran
Kodi S. Ravichandran

1 February 2012 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
TBTyler D. Bold
Tyler D. Bold
DDDaphne C. Davis
Daphne C. Davis
KPKristen K. Penberthy
Kristen K. Penberthy
LCLaura Cox
Laura Cox
JEJoel D. Ernst
Joel D. Ernst
BJBouke C. de Jong
Bouke C. de Jong
Background. When compared with Mycobacterium tuberculosis, individuals that live in the same household as an active case of smear-positive pulmonary tuberculosis exposed to M. africanum progress less frequently to active disease within 2 years. A putative ESX-1 secretion apparatus member, Rv3879c, is mutated in M. africanum, and individuals infected with M. africanum less frequently demonstrate T-cell responses to the ESX-1–secreted virulence factor ESAT-6 than those infected with M. tuberculosis. We hypothesized that less frequent progression is caused by impaired secretion of ESAT-6. Methods. We analyzed in vivo growth and in vitro secretion of ESAT-6 and CFP-10, comparing M. tuberculosis to M. africanum and a strain of M. africanum complemented with M. tuberculosis Rv3879c. Results. ESAT-6 and CFP-10 secretion were similar for all strains, although these were enriched in M. africanum cell lysates, suggesting a modest ESX-1 secretion defect unrelated to the Rv3879c mutation. In mice, M. africanum demonstrated smaller bacterial population sizes than M. tuberculosis but similar numbers and frequencies of ESAT-6–responsive T cells in the lungs. Conclusions. These results confirm impaired fitness of M. africanum in vivo and indicate that Rv3879c is not required for secretion of ESAT-6 or for its presentation as an antigen to T cells in vivo.

14 January 2019 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
SASanja Arandjelovic
Sanja Arandjelovic
JPJustin S. A. Perry
Justin S. A. Perry
CLChristopher Lucas
Christopher Lucas
KPKristen K. Penberthy
Kristen K. Penberthy
TKTae-Hyoun Kim
Tae-Hyoun Kim
KRKodi S. Ravichandran
Kodi S. Ravichandran

1 December 2014 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
KPKristen K. Penberthy
Kristen K. Penberthy
IJIgnacio J. Juncadella
Ignacio J. Juncadella
KRKodi S. Ravichandran
Kodi S. Ravichandran
Insult or injury to the lung epithelial cells from pathogens, pollutants, and allergens can initiate the process of apoptotic cell death. Although "Creola bodies," which are clusters of uncleared, apoptotic, epithelial cells, have been seen in the sputum of patients with asthma, the clearance of these dying epithelial cells and the consequence of failed clearance in the airway have not been directly addressed. We have observed that bronchial epithelial cells efficiently engulf their apoptotic neighbors and produce antiinflammatory cytokines when engulfing apoptotic cells. Furthermore, when the phagocytic capacity of bronchial epithelial cells was impaired, mice developed severe, IL-33-dependent, allergic airway inflammation. This inflammation could be ameliorated by exogenous administration of the antiinflammatory cytokine IL-10. Our data suggest that the process of apoptotic cell engulfment is a mechanism by which bronchial epithelial cells regulate the inflammatory environment within the lung. Collectively, these studies suggest that impaired engulfment pathways in airway epithelial cells can contribute to allergic airway inflammation and that targeting these pathways may be of benefit in human airway inflammation.